LPL and necrosis: Concerns have been raised about using heparin in the management of HTGAP because of an increased bleeding risk, for example, in patients with pancreatic necrosis, and the observed temporary depletion of LPL, if the hepatic degradation of LPL exceeds its production and release, resulting in rebound HTG [48,49,50].